Isis Pharmaceuticals, Inc. (ISIS) Posts Mixed Q4 Results
Tweet
Share
E-mailGet Alerts ISIS Hot Sheet
Price: $57.56 --0%
Financial Fact:
Diluted net loss (in dollars per share): 0.06
Today's EPS Names:
CCEL, FEIM, PLG, More
Financial Fact:
Diluted net loss (in dollars per share): 0.06
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) reported Q4 EPS of ($0.20), $0.02 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $32.4 million versus the consensus estimate of $30.3 million.
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- Wells Fargo previews Q2 midstream earnings, favors PAA and TRGP
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
